These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 2714733)
21. Hepatic haemodynamic changes after portacaval anastomosis in normal, cirrhotic and chronic prehepatic portally hypertensive rats. Romeo JM; Lopez-Farre A; Martin-Paredero V; Lopez-Novoa JM Br J Surg; 1990 Mar; 77(3):335-8. PubMed ID: 2322805 [TBL] [Abstract][Full Text] [Related]
22. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling. Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M; Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709 [TBL] [Abstract][Full Text] [Related]
23. [Portal-systemic shunting and hemodynamics of prehepatic portal hypertensive rat models]. Zhou YB; Leng X; Qi G Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):244-7. PubMed ID: 10374550 [TBL] [Abstract][Full Text] [Related]
24. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution. Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343 [TBL] [Abstract][Full Text] [Related]
25. Persistence of a hyperdynamic circulation in cirrhotic rats following removal of the sympathetic nervous system. Abergel A; Braillon A; Gaudin C; Kleber G; Lebrec D Gastroenterology; 1992 Feb; 102(2):656-60. PubMed ID: 1732135 [TBL] [Abstract][Full Text] [Related]
26. Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats. Lee SS; Sharkey KA Am J Physiol; 1993 May; 264(5 Pt 1):G868-73. PubMed ID: 8498513 [TBL] [Abstract][Full Text] [Related]
27. Changes in blood flow, portal pressure and shunting during the development of cirrhosis in response to beta-blockade. McLaren M; Braye S; Fleming J; Karran S; Taylor I Gut; 1987 Jun; 28(6):663-7. PubMed ID: 2887489 [TBL] [Abstract][Full Text] [Related]
28. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats]. Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839 [TBL] [Abstract][Full Text] [Related]
29. Blood digestion-induced splanchnic hyperemia and portal blood flow in portal hypertensive rats and the role of octreotide. Kotzampassi K; Eleftheriadis E J Gastroenterol; 1998 Oct; 33(5):678-83. PubMed ID: 9773932 [TBL] [Abstract][Full Text] [Related]
30. Effects of haemorrhage and volume expansion on portal-systemic collateral vascular resistance in conscious portal hypertensive rats. Koshy A; Sekiyama T; Cereda JM; Hadengue A; Girod C; Lebrec D Clin Sci (Lond); 1990 Feb; 78(2):193-7. PubMed ID: 2155748 [TBL] [Abstract][Full Text] [Related]
31. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction. Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356 [TBL] [Abstract][Full Text] [Related]
32. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model. Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788 [TBL] [Abstract][Full Text] [Related]
33. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Pizcueta P; Piqué JM; Fernández M; Bosch J; Rodés J; Whittle BJ; Moncada S Gastroenterology; 1992 Dec; 103(6):1909-15. PubMed ID: 1451984 [TBL] [Abstract][Full Text] [Related]
34. Systemic and splanchnic haemodynamic effects of pentifylline in rats with portal hypertension. Dagenais M; Pomier-Layrargues G; Rocheleau B; Giroux L; Huet PM Clin Sci (Lond); 1992 Jul; 83(1):41-5. PubMed ID: 1325320 [TBL] [Abstract][Full Text] [Related]
35. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation. Oberti F; Pilette C; Rifflet H; Maïga MY; Moreau A; Gallois Y; Girault A; le Bouil A; Le Jeune JJ; Saumet JL; Feldmann G; Calès P J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625 [TBL] [Abstract][Full Text] [Related]
36. On the pathogenesis of portal hypertension in cirrhosis of the liver. Shibayama Y Liver; 1988 Apr; 8(2):95-9. PubMed ID: 3367713 [TBL] [Abstract][Full Text] [Related]
37. Combined treatment of portal hypertension with ritanserin and propranolol in conscious and unrestrained cirrhotic rats. Pomier-Layrargues G; Giroux L; Rocheleau B; Huet PM Hepatology; 1992 May; 15(5):878-82. PubMed ID: 1568730 [TBL] [Abstract][Full Text] [Related]
38. Portal venous pressure and portasystemic shunting in experimental portal hypertension. Geraghty JG; Angerson WJ; Carter DC Am J Physiol; 1989 Jul; 257(1 Pt 1):G52-7. PubMed ID: 2750909 [TBL] [Abstract][Full Text] [Related]
39. Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow. Van de Casteele M; Sägesser H; Zimmermann H; Reichen J Pharmacol Ther; 2001 Apr; 90(1):35-43. PubMed ID: 11448724 [TBL] [Abstract][Full Text] [Related]
40. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol. Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]